Pleiotropic effects of deleterious alleles at the "motheaten" locus - PubMed (original) (raw)

Pleiotropic effects of deleterious alleles at the "motheaten" locus

L D Shultz. Curr Top Microbiol Immunol. 1988.

No abstract available

PubMed Disclaimer

Similar articles

• B and T cells are not required for the viable motheaten phenotype.
  Yu CC, Tsui HW, Ngan BY, Shulman MJ, Wu GE, Tsui FW. Yu CC, et al. J Exp Med. 1996 Feb 1;183(2):371-80. doi: 10.1084/jem.183.2.371. J Exp Med. 1996. PMID: 8627150 Free PMC article.
• Immune dysfunctions and activation of natural killer cells in human IL-2 and IL-2/IL-2 receptor L-chain transgenic mice.
  Ishida Y, Nishi M, Taguchi O, Inaba K, Minato N, Kawaichi M, Honjo T. Ishida Y, et al. Cold Spring Harb Symp Quant Biol. 1989;54 Pt 2:695-704. doi: 10.1101/sqb.1989.054.01.082. Cold Spring Harb Symp Quant Biol. 1989. PMID: 2640624 No abstract available.
• Hematopoiesis and models of immunodeficiency.
  Shultz LD. Shultz LD. Semin Immunol. 1991 Nov;3(6):397-408. Semin Immunol. 1991. PMID: 1799670 Review.
• "Viable motheaten," a new allele at the motheaten locus. I. Pathology.
  Shultz LD, Coman DR, Bailey CL, Beamer WG, Sidman CL. Shultz LD, et al. Am J Pathol. 1984 Aug;116(2):179-92. Am J Pathol. 1984. PMID: 6380298 Free PMC article.

Cited by

• Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1.
  Watson HA, Dolton G, Ohme J, Ladell K, Vigar M, Wehenkel S, Hindley J, Mohammed RN, Miners K, Luckwell RA, Price DA, Matthews RJ, Ager A. Watson HA, et al. Immunol Cell Biol. 2016 Sep;94(8):802-8. doi: 10.1038/icb.2016.45. Epub 2016 Jul 19. Immunol Cell Biol. 2016. PMID: 27430370 Free PMC article.
• Shp1 regulates T cell homeostasis by limiting IL-4 signals.
  Johnson DJ, Pao LI, Dhanji S, Murakami K, Ohashi PS, Neel BG. Johnson DJ, et al. J Exp Med. 2013 Jul 1;210(7):1419-31. doi: 10.1084/jem.20122239. J Exp Med. 2013. PMID: 23797092 Free PMC article.
• Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger.
  Croker BA, Lawson BR, Rutschmann S, Berger M, Eidenschenk C, Blasius AL, Moresco EM, Sovath S, Cengia L, Shultz LD, Theofilopoulos AN, Pettersson S, Beutler BA. Croker BA, et al. Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15028-33. doi: 10.1073/pnas.0806619105. Epub 2008 Sep 19. Proc Natl Acad Sci U S A. 2008. PMID: 18806225 Free PMC article.
• CTLA-4 and tolerance: the biochemical point of view.
  Chikuma S, Bluestone JA. Chikuma S, et al. Immunol Res. 2003;28(3):241-53. doi: 10.1385/IR:28:3:241. Immunol Res. 2003. PMID: 14713717 Review.
• Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.
  Umeda S, Beamer WG, Takagi K, Naito M, Hayashi S, Yonemitsu H, Yi T, Shultz LD. Umeda S, et al. Am J Pathol. 1999 Jul;155(1):223-33. doi: 10.1016/s0002-9440(10)65116-4. Am J Pathol. 1999. PMID: 10393854 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information